• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Ranbaxy File Suit Against Two US Drug Firms

      Posted AtNew Kerala.com

      Ranbaxy Pharmaceuticals, the US arm of the Indian drugs manufacturer, has filed a joint complaint with Agvar Chemicals against Barr Laboratories and Teva Pharmaceuticals for breach of contract.

      The suit seeks damages and relief for the breach of contract, fraud and tortuous interference in the commercialisation of fexofenadine hydrochloride tablets in the American healthcare market, the company said in a statement Thursday.

      Fexofenadine hydrochloride is prescribed for the relief of symptoms associated with seasonal allergic rhinitis, as also for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria.

      Ranbaxy said it operated in good faith for five years to lend expertise to Barr in developing fexofenadine hydrochloride tablets and by investing in facilities to meet the demands of Barr only to be surprised by its tie-up with Teva.

      "We believe this is a breach of our agreement with Barr and accordingly are now seeking all appropriate relief from a state court in New Jersey," said Jay Deshmukh, vice president of global intellectual property for Ranbaxy.

      Florida-based Ranbaxy Pharmaceuticals is engaged in the sale and distribution of generic and branded prescription products in the US healthcare system.

      Meanwhile, Ranbaxy has decided to appeal a British High Court riling that the Indian company's atorvastatin product infringed on one of Pfizer's European patents on cholesterol lowering drug marketed as Lipitor.

      Ranbaxy's proposed product was found to infringe Warner Lambert and Pfizer's European patent following a hearing in the British court July 18-25.

      October 13, 2005


       

      Share this Article!

    Back to top^